Cite
HARVARD Citation
Tevelev, B. et al. (2023). A genetic off‐target event in a site‐specific integration cell line expressing monoclonal antibody has no impact on commercial suitability. Biotechnology progress. p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tevelev, B. et al. (2023). A genetic off‐target event in a site‐specific integration cell line expressing monoclonal antibody has no impact on commercial suitability. Biotechnology progress. p. n/a. [Online].